Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 6, 2023
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
Thu, January 5, 2023
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
Etzer Darout Initiated (AZN) at Buy and Held Target at $82 on, Jan 5th, 2023
Etzer Darout of BMO Capital, Initiated "AstraZeneca PLC" (AZN) at Buy and Held Target at $82 on, Jan 5th, 2023.
Etzer has made no other calls on AZN in the last 4 months.
There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, 0 agree with Etzer's Rating of Hold.
This is the rating of the analyst that currently disagrees with Etzer
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $79 on, Monday, November 14th, 2022
